TROPICAMIDUM 5 mg /Ml Drops
Prescription review online
A doctor will review your case and decide whether a prescription is medically appropriate.
Talk to a doctor about this medicine
Discuss your symptoms and possible next steps in a quick online consultation.
How to use Tropicamidum Vzf 0,5%
Contents of the leaflet
- Package Leaflet: Information for the Patient
- What is Tropicamidum WZF 0.5% and what is it used for
- Important information before using Tropicamidum WZF 0.5%
- How to use Tropicamidum WZF 0.5%
- Possible side effects
- How to store Tropicamidum WZF 0.5%
- Contents of the package and other information
Package Leaflet: Information for the Patient
TROPICAMIDUM WZF 0.5%, 5 mg/ml, eye drops, solution
Tropicamidum
Read the package leaflet carefully before using the medicine, as it contains important information for the patient.
- Keep this package leaflet, you may need to read it again.
- In case of any doubts, consult a doctor or pharmacist.
- This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm them, even if their symptoms are the same as yours.
- If the patient experiences any side effects, including those not listed in this package leaflet, they should inform their doctor or pharmacist. See section 4.
Table of Contents of the Package Leaflet
- 1. What is Tropicamidum WZF 0.5% and what is it used for
- 2. Important information before using Tropicamidum WZF 0.5%
- 3. How to use Tropicamidum WZF 0.5%
- 4. Possible side effects
- 5. How to store Tropicamidum WZF 0.5%
- 6. Contents of the package and other information
1. What is Tropicamidum WZF 0.5% and what is it used for
The medicine contains tropicamide, which, when used locally in the eye, dilates the pupil and paralyzes the eye's accommodation (ability to adapt to sharp vision of objects at different distances).
The medicine is used:
- in ophthalmic diagnostics - to examine the fundus of the eye (ophthalmoscopy);
- in preoperative conditions requiring the use of a short-acting pupil dilator.
Not sure if this medicine is right for you?
Discuss your symptoms and treatment with a doctor online.
2. Important information before using Tropicamidum WZF 0.5%
When not to use Tropicamidum WZF 0.5%
- if the patient is allergic to tropicamide or any other ingredient of this medicine (listed in section 6);
- if the patient has primary glaucoma (increased pressure in the eyes) with a tendency to angle closure;
- if the patient has glaucoma with a narrow angle;
- in the case of soft contact lenses, due to the presence of benzalkonium chloride in the composition.
Warnings and precautions
Before starting to use Tropicamidum WZF 0.5%, the patient should discuss it with their doctor or pharmacist.
- Before using the medicine to dilate the pupil for an eye examination, the doctor will perform a diagnostic test for narrow-angle glaucoma to prevent a possible acute glaucoma attack after administering tropicamide.
- Particular caution should be exercised in people who are hypersensitive to belladonna alkaloids.
- In patients with increased sensitivity to anticholinergic drugs, psychotic reactions and behavioral disorders may occur after tropicamide administration.
- After each administration of the medicine, the patient should wash their hands to remove any remaining tropicamide.
Children
When administering the medicine, particular caution is recommended in children, as side effects may occur (see section 4 of the package leaflet). Tropicamide may cause central nervous system disorders, which can be dangerous for infants and children.
If the medicine is accidentally ingested by a child, it may cause toxic effects, so, like all other medicines, it is recommended to store it out of the reach of children.
Tropicamidum WZF 0.5% and other medicines
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
The effect of tropicamide is enhanced by medicines used in Parkinson's disease (e.g., amantadine), some antihistamines (e.g., clemastine), medicines used in psychiatric disorders (e.g., chlorpromazine and haloperidol), and tricyclic antidepressants (e.g., imipramine, amitriptyline).
Pregnancy, breastfeeding, and fertility
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine.
The medicine may be used in pregnant women only when, in the doctor's opinion, its use is necessary.
The risk to the breastfed child cannot be excluded.
The decision to continue or stop breastfeeding, or to continue or stop using tropicamide, will be made by the doctor after weighing the benefits of breastfeeding for the child and the use of tropicamide in the mother.
There is no data on the effect of the medicine on fertility.
Driving and using machines
After using the medicine, vision disturbances and photophobia may occur. The patient should not drive or operate machines until their vision returns to normal, which usually happens about 6 hours after using the medicine.
Tropicamidum WZF 0.5% contains benzalkonium chloride
The medicine contains 0.1 mg of benzalkonium chloride in each ml of solution. Benzalkonium chloride may be absorbed by soft contact lenses and change their color. The patient should remove their contact lenses before administering the medicine and wait at least 15 minutes before putting them back on.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer on the front of the eye). If the patient experiences any abnormal sensations in the eye, stinging, or eye pain after using the medicine, they should contact their doctor.
3. How to use Tropicamidum WZF 0.5%
This medicine should always be used exactly as directed by the doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Usually, the medicine is used as described below.
Adults, elderly patients, and children
- Eye examination: 1 to 2 drops should be administered into the conjunctival sac 15 to 20 minutes before the examination.
- To dilate the pupil: 2 drops should be administered into the conjunctival sac (at 5-minute intervals). If it is not possible to examine the patient within 15-30 minutes after administration, 1 additional drop may be administered to prolong the pupil-dilating effect. The maximum dilation of the pupil occurs about 15 minutes after administration. The effect of the medicine lasts for up to 3 hours.
Method of administration
Tropicamidum WZF 0.5% is intended for external use - it should be administered locally to the eye (eyes).
The patient should not touch the dropper tip to the eye, eyelids, or any other surfaces, as this may contaminate the contents of the bottle. Using contaminated drops can lead to serious complications, even vision loss.
- 1. Before administering the medicine, the patient should wash their hands thoroughly.
- 2. The patient should unscrew the cap on the bottle.
- 3. The patient should tilt their head back and pull the lower eyelid down to create a pocket between the eyelid and the eye.
- 4. The patient should turn the bottle upside down and gently press the thumb or index finger on the wall until one drop of the medicine falls into the eye. The patient should not touch the dropper tip to the eye or eyelids. If the drop does not get into the eye, the patient should administer the next drop.
- 5. Immediately after administering the medicine, the patient should gently press the inner corner of the eye for about 1 minute. This will help reduce the risk of systemic side effects.
- 6. If the doctor has recommended administering the medicine to the other eye as well, the patient should repeat the steps from points 3, 4, and 5.
- 7. The dropper is designed to accurately measure the drops, so the patient should not enlarge the opening of the dropper.
- 8. After administering the medicine, the patient should screw the cap back on the bottle, but not too tightly.
Using a higher dose of Tropicamidum WZF 0.5% than recommended
In case of excessive absorption of tropicamide into the systemic circulation, systemic toxic effects may occur (especially in children), characterized by: facial flushing, dryness of the mucous membranes of the mouth (in children, a rash may occur), vision disturbances, rapid and irregular heartbeat, fever, abdominal distension in infants, convulsions, hallucinations, and loss of neuromuscular coordination. If these symptoms occur or the medicine has been used incorrectly (e.g., ingested), the patient should immediately consult their doctor or go to the hospital. In infants and small children, it is recommended to maintain a moist body surface. If the medicine has been ingested, vomiting can be induced.
Started taking the medicine and have questions?
Discuss your symptoms and treatment with a doctor online.
4. Possible side effects
Like all medicines, Tropicamidum WZF 0.5% can cause side effects, although not everybody gets them.
If the patient experiences any allergic reactions, they should stop using Tropicamidum WZF 0.5% and immediately consult their doctor.
Local side effects may occur:
Frequency not known (frequency cannot be estimated from the available data):
- increased pressure in the eyes;
- transient stinging in the eye;
- photophobia, resulting from pupil dilation. Prolonged use of the medicine may cause local irritation, hyperemia, edema, and conjunctivitis.
Systemic side effects may occur:
Frequency not known (frequency cannot be estimated from the available data):
- dryness of the mucous membranes of the mouth;
- facial flushing, dry skin;
- irregular heartbeat;
- sudden need to urinate;
- slowing of gastrointestinal peristalsis leading to constipation;
- vomiting;
- dizziness;
- unsteady gait.
Additional side effects in children
Frequency not known (frequency cannot be estimated from the available data): rash, psychotic reactions (e.g., seeing or hearing things that do not exist, delusions), behavioral disorders, respiratory and cardiovascular failure, and abdominal distension in infants.
Tropicamide may cause central nervous system disorders, which can be dangerous in infants and children.
If the patient experiences any of these symptoms while using the medicine, they should stop using Tropicamidum WZF 0.5% and immediately consult their doctor or the Emergency Department of the nearest hospital.
Reporting side effects
If the patient experiences any side effects, including those not listed in the package leaflet, they should inform their doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
5. How to store Tropicamidum WZF 0.5%
Store in a temperature below 25°C.
Keep the bottle tightly closed.
The medicine should be stored out of sight and reach of children.
Shelf life after first opening the bottle: 4 weeks.
After this period, the bottle with the remaining medicine should be discarded.
Do not use this medicine after the expiry date stated on the carton and bottle.
The expiry date stated on the packaging refers to the last day of the specified month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot means the batch number.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
6. Contents of the package and other information
What does Tropicamidum WZF 0.5% contain
- The active substance of the medicine is tropicamide. Each ml of solution contains 5 mg of tropicamide.
- The other ingredients are: sodium chloride; disodium edetate; benzalkonium chloride solution; hydrochloric acid diluted (to adjust pH); purified water.
What Tropicamidum WZF 0.5% looks like and what the package contains
Tropicamidum WZF 0.5% is a sterile eye drop solution in the form of a colorless, transparent liquid.
The package contains 2 polyethylene bottles of 5 ml solution each, in a cardboard box.
Marketing authorization holder
Polpharma S.A.
Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Manufacturer
Jadran-Galenski Laboratorij d.d.
Svilno 20, 51000 Rijeka
Croatia
Date of the last revision of the package leaflet
- Country of registration
- Dosage formDrops, 5 mg/ml
- ATC codeS01FA06
- Active substance
- Prescription requiredYes
- Manufacturer
- ImporterJadran-Galenski laboratorij d.d.
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to Tropicamidum Vzf 0,5%Dosage form: Drops, 10 mg/mlActive substance: tropicamideManufacturer: Jadran-Galenski laboratorij d.d.Prescription requiredDosage form: Drops, 10 mg/mlActive substance: atropineManufacturer: Warszawskie Zakłady Farmaceutyczne POLFA S.A.Prescription requiredDosage form: Drops, 10 mg/mlActive substance: cyclopentolate
Online doctors for Tropicamidum Vzf 0,5%
Discuss questions about Tropicamidum Vzf 0,5%, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get Tropicamidum Vzf 0,5% Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Tropicamidum Vzf 0,5% requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in Tropicamidum Vzf 0,5% is tropicamide. This information helps identify medicines with the same composition but different brand names.
Tropicamidum Vzf 0,5% is manufactured by Jadran-Galenski laboratorij d.d.. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Tropicamidum Vzf 0,5% is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy Tropicamidum Vzf 0,5% in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (tropicamide) include Tropicamidum Vzf 1%, Atropinum sulfuricum Vzf 1%, Cikloftial. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
